Conference Series llc Ltd provides the perfect platform for global networking and our Epilepsy Treatment 2018 conference aims to gather the Professors, Researchers, Business Delegates, and Scientists, students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences.
We are truly delighted to invite you to attend the 4th World Congress on Epilepsy and Treatment, during Nov 16-17, 2018 at Toyko, Japan. Epilepsy treatment 2018 will provide two days of robust discussions for the treatment of various types of Epilepsy and its effects in pregnant women, Infantile Seizures, Genetic causes, mutations and other novel therapeutic and diagnostic approaches of Epilepsy. It will also explore new ideas and concepts on a global scale.
Epilepsy is the fourth common neurodegenerative disorder and affects people of all ages. Public perception and misunderstanding of epilepsy causes challenges often worse than the seizures.
The seizures in epilepsy can be associated with brain injury or a family tendency, but most of the time the cause is unknown.
“Seizures are caused by disturbances in the electrical activity of the brain”
Epilepsy is a very common neurodegenerative disorder that affects about 65 million people worldwide. In the United States, 1 in 26 people will develop epilepsy at few points in their lifetime. Ten out of thousand numbers of people on earth develops active seizures at once in life. In the United State 150,000 number of people lives with epilepsy in each year.1/3rd number of people with epilepsy who live with uncontrollable seizures because no available treatment works for them. Cause of epilepsy is unknown for those ten people out of six.
Scope & Importance
Epilepsy is a non-communicable disorder of the brain that affects people of all ages. According to WHO (World Health Organization) statistics more than 50 million people are affected in the world. It is estimated that every year nearly 2.4 million people are diagnosed with epilepsy and the population with active epilepsy is between 4 to10 per 1000 people. Approximately 50 million people in the world have epilepsy, now days which is one of the common neurological diseases globally. Nearly 80% people in the world live in low- and middle-income countries with epilepsy. Approximately 70% of the people with epilepsy living in low-and middle-income countries get treatment as they need & rest of 3/4th people, they do not get. In different parts of the world, many families with epilepsy suffer from stigma and discrimination.
WHY TO ATTEND THE CONFERENCE
Epilepsy Treatment 2018 conference brings together Speakers and attendees and decision-makers from different biotechnology and medical companies, major pharmaceutical and device companies, and researchers and innovators at the cutting-edge of epilepsy and CNS treatment advances. Also to create an agenda with highly innovative topics on epilepsy treatment, therapeutic innovation, and product development. Initiate demos, share information, come across with eminent personalities, and create novel antiepileptic line and latest diagnosticmethods at this outstanding event.
Targeted audience
- Epileptologists
- Neurologists
- Pharmacists
- Research scientists
- Anti- Epileptic drug Industries
- Epilepsy associations & foundation
- Professors and Students from Academia in the study of Epilepsy field.
- Epilepsy organizations Biopharmaceutical (drug design and discovery) companies
Pharma Sources Insight January 2025
